Innovative Reproductive Solutions

Country/Region: United Kingdom     State/Province: England

Main Products: Health

Company Introduction
The E-tegrity Test is used to determine receptive lining of the uterus & checks for the presence of the Beta-3 integrin. This test, used along with your other medical information, helps your doctor decide which treatment is right for you.
Company Overview

Business Type: Manufacturer, Retailer

Year Established: 2012

Employees: Above 1000 People

Plant Area: 50,000-100,000 square meters

Business Information

Main Markets: South America 10% Africa 9% Eastern Asia 12% Domestic Market 12% North America 10% Eastern Europe 12% Southern Europe 11% Mid East 8% Northern Europe 8% Oceania 8%

Trade Capacity: FOB, CIP, DDU

Contract Manufacturing: OEM Service Offered Design Service Offered

Nearest Port: Boston

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: Above US$100 Million

Export Revenue: US$50 Million - US$100 Million

Annual Output: US$10 Million - US$50 Million

Registered Capital: Below US$1 Million

Export Percentage: 21% - 30%

Payment Modes: USD, CAD, CHF

Lead Time: 8 days

Import/Export Mode: Have Own Export License

Product Showcase
health

CL-Link > Health & Medicines in United Kingdom Health & Medicines in England Surgical Instrument in United Kingdom Surgical Instrument in England Surgical Instruments in United Kingdom Surgical Instruments in England